|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 73.50 GBX | -3.29% |
|
+1.80% | +26.72% |
| 06-25 | EARNINGS AND TRADING: Clontarf loss narrows, eyes new opportunities | AN |
| 06-25 | Avacta Therapeutics Reaches Study Design Terms With US FDA for Salivary Gland Cancer Therapy | MT |
| Market Cap | 356M 472M 413M 382M 671M 44.66B 683M 4.58B 1.78B 22.04B 1.77B 1.73B 76.77B | P/E 2026 * |
-11.4x | P/E 2027 * | -11.2x |
|---|---|---|---|---|---|
| Enterprise Value | 356M 472M 413M 382M 671M 44.66B 683M 4.58B 1.78B 22.04B 1.77B 1.73B 76.77B | EV / Sales 2026 * |
-
| EV / Sales 2027 * | - |
| Free-Float |
98.8% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Avacta Group Plc
| 24-12-10 | Deutsche Bank Upgrades Avacta Group to Hold | MT |
| 24-12-10 | RBC raises Hikma; JPMorgan cuts Schroders | AN |
| 24-09-17 | Deutsche Bank Downgrades Avacta Group to Sell | MT |
| 24-09-17 | Berenberg, Peel cut TT Electronics to 'hold' | AN |
| 24-06-19 | Deutsche Raises Avacta to Hold from Sell | MT |
| 1 day | -3.29% | ||
| 1 week | +1.80% | ||
| Current month | -6.96% | ||
| 1 month | -0.68% | ||
| 3 months | +13.95% | ||
| 6 months | +26.72% | ||
| Current year | +26.72% |
| 1 week | 71 |  | 82 |
| 1 month | 66.9 | | 82 |
| Current year | 48 | | 92 |
| 1 year | 28 | | 92 |
| 3 years | 26 | | 166.98 |
| 5 years | 26 | | 187.98 |
| 10 years | 13 | | 291.8 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 56 | 2024-03-31 | |
Brian Hahn
DFI | Director of Finance/CFO | 51 | 2025-01-21 |
| Chief Tech/Sci/R&D Officer | - | 2026-02-08 |
| Director | Title | Age | Since |
|---|---|---|---|
Paul Fry
BRD | Director/Board Member | 60 | 2020-02-02 |
Mark Goldberg
BRD | Director/Board Member | 71 | 2021-08-16 |
| Director/Board Member | 56 | 2022-03-17 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 24-09-01 | Sell | Chief Financial Officer | 500,000 | 0.1393% | ||
| 24-09-01 | Free | Chief Executive Officer | 3,600,000 | 1.0027% | ||
| 24-09-01 | Fiscal year | Chief Financial Officer | 500,000 | 0.1393% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -3.29% | +1.80% | +137.10% | -31.63% | 472M | |
| +3.31% | -0.20% | +72.71% | +128.31% | 55.78B | |
| -1.32% | +16.55% | +89.14% | +101.41% | 55.66B | |
| -0.80% | +3.06% | -12.29% | -13.47% | 23.84B | |
| +2.85% | +4.92% | +6.50% | +407.96% | 22.7B | |
| +4.45% | +5.06% | +36.50% | -30.43% | 16.12B | |
| +0.59% | +6.46% | +24.00% | +186.00% | 13.64B | |
| +5.51% | +22.37% | +171.85% | +333.54% | 14.8B | |
| +0.99% | +3.76% | +76.03% | +130.62% | 12.16B | |
| -1.79% | +6.99% | +159.08% | +162.42% | 11.85B | |
| Average | +1.05% | +6.09% | +76.06% | +137.47% | 22.7B | |
| Weighted average by Cap. | +1.35% | +5.02% | +66.98% | +141.93% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | - | - |
| Net income | -30.5M -40.46M -35.42M -32.7M -57.46M -3.83B -58.49M -392M -152M -1.89B -152M -149M -6.58B | - |
| Net Debt | - | 27.15 36.03 31.54 29.11 51.16 3.41K 52.08 349.18 135.56 1.68K 135.36 132.33 5.86K |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-06-30 | GBX 73.50 | -3.29% | 1,151,602 |
| 26-06-29 | GBX 76.00 | -3.80% | 2,240,646 |
| 26-06-26 | GBX 79.00 | +3.95% | 3,162,459 |
| 26-06-25 | GBX 76.00 | +4.83% | 2,753,318 |
| 26-06-24 | GBX 72.50 | +0.42% | 850,895 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Annual profits - Rate of surprise
- Stock Market
- Stocks
- AVCT Stock
Select your edition
All financial news and data tailored to specific country editions
